Skip to main content

Latest News

NICE approves use of new treatment for advanced metastatic bladder cancer

Enfortumab Vedotin combined with Pembrolizumab will now be available for eligible patients in the UK

The British Association of Urological Surgeons (BAUS) welcomes the decision by the National Institute for Health and Care Excellence (NICE) to approve the use of combination therapy enfortumab vedotin (Padcev) with pembrolizumab as a first-line treatment for untreated unresectable or metastatic urothelial (bladder) cancer in patients who are eligible for platinum-based chemotherapy. Urothelial cancer affects cells that form the inner...

Upcoming Event

18 – 19 Sep 2025

Fundamentals of Transurethral Resection & Ureteroscopic Skills Using Animal & Human Cadaveric Models

Surgical Skills Centre, Level 5, Ninewells Hospital, Dundee, Scotland

This is a one and a half day practical course, ideal for Urology trainees who are already undertaking or about to start training in endoscopic urology. The emphasis during the course will be hands-on training mainly on restructured animal tissue models and also Thiel embalmed human cadavers, whilst the relevant key clinical elements will be...